🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research is being done to evaluate the safety and effectiveness of the...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2022-08-09
Trial ID
NCT05417386
This study is being done to evaluate the safety and efficacy of adding NIS7...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2023-01-06
Trial ID
NCT05546411
Treatments Being Tested
The purpose of this study was to investigate the safety, pharmacokinetics a...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-09-26
Trial ID
NCT04097821
Treatments Being Tested
To characterize the safety and tolerability of NIS793 as single agent and i...
Status
Completed
Location
Sarah Cannon Research Institute SC
Start Date
2017-04-25
Trial ID
NCT02947165
The purpose of this study was to characterize the safety, tolerability and ...
Status
Terminated
Location
City Of Hope National Med Center Oncology
Start Date
2021-06-18
Trial ID
NCT04810611
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of NIS793...
Status
Completed
Location
Highlands Oncology Group
Start Date
2021-09-30
Trial ID
NCT04935359
Treatments Being Tested
The purpose of this study is to investigate the safety, pharmacokinetics (P...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-11-30
Trial ID
NCT04283526
Treatments Being Tested
The purpose of this Phase II study is to assess the efficacy and safety of ...
Status
Terminated
Location
Winship Cancer Institute
Start Date
2020-10-16
Trial ID
NCT04390763
Treatments Being Tested
The purpose of this study is to evaluate the preliminary efficacy and safet...
Status
Terminated
Location
The Angeles Clinic and Research Institute
Start Date
2021-11-15
Trial ID
NCT04952753
Treatments Being Tested